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Type 2 diabetes is characterized by insulin resis-
tance and pancreatic b cell dysfunction, the latter
possibly caused by a defect in insulin signaling in
b cells. Inhibition of class IA phosphatidylinositol
3-kinase (PI3K), using a mouse model lacking the
pik3r1 gene specifically in b cells and the pik3r2
gene systemically (bDKO mouse), results in glucose
intolerance and reduced insulin secretion in
response to glucose. b cells of bDKO mice had
defective exocytosis machinery due to decreased
expression of soluble N-ethylmaleimide attachment
protein receptor (SNARE) complex proteins and
loss of cell-cell synchronization in terms of Ca2+
influx. These defects were normalized by expression
of a constitutively active form of Akt in the islets of
bDKO mice, preserving insulin secretion in response
to glucose. The class IA PI3K pathway in b cells
in vivo is important in the regulation of insulin
secretion and may be a therapeutic target for type 2
diabetes.
INTRODUCTION
Type 2 diabetes mellitus (T2DM) is characterized by peripheral
insulin resistance and b cell dysfunction (Kahn et al., 2006).
Previous studies have suggested that the latter can develop by
impairing insulin signaling in b cells. Indeed, it has been shown
that b cell-specific insulin receptor (IR) knockout (bIRKO) or
insulin-like growth factor-1 receptor (IGFR) knockout (bIGFRKO)Cell Mmice demonstrate a defect in glucose-stimulated insulin secre-
tion (GSIS), especially in the early phase, with decreased b cell
mass only in bIRKO mice (Kulkarni et al., 1999, 2002). Double
knockout of IR and IGFR in b cells results in severe diabetes
by hypoinsulinemia with a marked b cell loss and a defect in
insulin secretion (Ueki et al., 2006). Insulin receptor substrate 2
(IRS2), one of the substrates for IR and IGFR, mainly mediates
the signal to regulate b cell mass (Kubota et al., 2004; Lin
et al., 2004). Furthermore, phosphatidylinositol-dependent
kinase 1 (PDK1) and its downstream Akt are important in the
regulation of b cell growth and function (Bernal-Mizrachi et al.,
2001; Hashimoto et al., 2006; Tuttle et al., 2001). Class IA phos-
phatidylinositol 3-kinase (PI3K) is activated by growth factor
receptors and plays a crucial role in growth and metabolism
(Engelman et al., 2006; Vanhaesebroeck et al., 2010). It is likely
that class IA PI3K downstream of the IR(IGFR)/IRS proteins
transmits the signal to regulate b cell function and mass through
the PDK1/Akt signaling pathway, although the mechanism
remains poorly understood.
The class IA PI3Kmolecule comprises a regulatory and a cata-
lytic subunit, with the holoenzyme catalytically producing phos-
phatidylinositol (3,4,5)-trisphosphate (PIP3) thereby transmitting
the signals for metabolism, proliferation, and antiapoptosis.
The regulatory subunits per se have dual roles in these signals:
(1) a positive role stabilizing the catalytic subunit and bridging
between the catalytic subunit and phosphotyrosyl proteins (Yu
et al., 1998) and (2) a negative role interfering with binding of
the holoenzyme to phosphotyrosyl proteins as a monomer and
transmitting negative signals to activate Akt by an unexplored
mechanism (Taniguchi et al., 2006c, 2007; Ueki et al., 2003).
The regulatory subunits are derived from three different genes,
pik3r1, pik3r2, and pik3r3, which result in multiple isoforms of
the regulatory subunits, such as p85a, its splicing variants,
p55a and p50a, and p85b. Among the regulatory subunits,etabolism 12, 619–632, December 1, 2010 ª2010 Elsevier Inc. 619
Figure 1. Decreased Expressions of Insulin
SignalingMolecules in db/dbMice in Accor-
dance with Age-Dependent Attenuated
Insulin Secretion
(A–C) Profiles of body weight (A), blood glucose
levels (B), and plasma insulin concentrations (C)
in db/db and +/+ mice at 6, 10, and 14 weeks of
age (n = 5–6).
(D) mRNA levels of insulin signaling molecules.
Expressions of the indicated genes were deter-
mined by quantitative RT-PCR of total RNA
isolated from islets of db/db and +/+ mice at 6,
10, 14, and 18weeks of age (n = 4–6). Data are pre-
sented as the means ± SEM.
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Role of PI3K in b Cell Functionsp85a represents over 70% of the total, with a further 20% repre-
sented by p85b (Ueki et al., 2002a). Thus, these two molecules
are the major regulatory subunits of class IA PI3K.
The deletion of regulatory subunit(s) leads to improved insulin
sensitivity (Fruman et al., 2000; Terauchi et al., 1999). This is
presumably because of a reduction in the negative effects of
the regulatory subunits on the downstream signals. In contrast,
tissue-specific knockout of pik3r1 on the whole-body knockout
of pik3r2 was expected to almost completely shut down the
actions mediated by PI3K and to be a suitable system for evalu-
ating the role of class IA PI3K in specific tissues. The important
roles of class IA PI3Ks in heart, skeletal muscle, liver, and pro-
opiomelanocortin (POMC) neurons have been revealed by
researchers using this method (Hill et al., 2008; Luo et al.,
2005; Taniguchi et al., 2006b).620 Cell Metabolism 12, 619–632, December 1, 2010 ª2010 Elsevier Inc.This study has explored the function of
class IA PI3Ks in the regulation of insulin
secretion in b cells by using b cell-specific
knockout mice. Together with the find-
ings using diabetic db/dbmice, it is likely
that decreased class IA PI3K activity in
b cells contributes to the impaired b cell
function in diabetes, and enhancing this
pathway would be a therapeutic strategy
for diabetes.
RESULTS
Insulin Signaling in db/db Islets
In humans, insulin secretion has been sug-
gested to be transiently increased during
insulin-resistant prediabetic state but
progressively decline once diabetes
develops (Rhodes, 2005). Similarly, it is
known that in the db/dbmouse, an obese
and diabetic animal model, insulin secre-
tion and b cell mass are transiently
increased against severe peripheral insulin
resistance induced by obesity, but there-
after b cells progressively fail to compen-
sate, leading to marked hyperglycemia
(Hummel et al., 1972; Lee et al., 1996).
Indeed, circulating insulin levels gradually
declined as the mice aged, despite severeobesity and hyperglycemia (Figures 1A–1C). Interestingly, expres-
sion of insulin/IGF-1 signaling molecules, including class IA PI3K
subunits, except irs1, was transiently increased in db/db islets
during the markedly hyperinsulinemic period, then declined along
with insulin secretion (Figures 1C and 1D). This is consistent with
the previous findings that irs2, but not irs1, plays a crucial role in
compensatory b cell hyperplasia in response to peripheral insulin
resistance (Araki et al., 1994; Kubota et al., 2000; Tamemoto
et al., 1994). We hypothesized, based on these data, that class
IA PI3K would play a pivotal role in the regulation of insulin secre-
tion downstream of IR(IGFR)/IRS2.
Loss of PI3K Subunits Led to Impaired PI3K Signaling
To inhibit PI3K signaling in b cells, we generated b cell-specific
pik3r1 knockout (bPik3r1KO) mice using rat insulin promoter-Cre
Figure 2. Pancreatic b Cell-Specific Dele-
tion of the pik3r1 Gene and Inhibition of
PI3K Signaling in b Cells in bPik3r1KO and
bDKO Mice
(A and B) Immunohistochemical analysis using
pancreas sections from 8-week-old male indi-
cated genotypes of mice. Staining by p85a-spe-
cific antibody using pancreas sections of RIP-Cre
and bPik3r1KO mice is shown in (A) (scale
bar = 100 mm). Staining by pan-p85 (p85a and
p85b) antibody using DAB substrate on pancreas
sections of Flox, bPik3r1KO, Pik3r2KO, and
bDKO mice is shown in (B) (scale bar = 100 mm).
(C) Protein expression of p85 regulatory subunits
in islets, liver, skeletal muscle, and hypothalami
in 8-week-old male mice assessed by western
blotting.
(D) Decreased PI3K activity detected by accumu-
lation of PIP3 in response to glucose stimulation.
Staining for PIP3 using pancreatic sections of
Flox, RIP-Cre, and bPik3r1KO mice is shown
(scale bar = 100 mm).
(E and F) Subcellular localization of FoxO1 in
pancreatic b cell. Immunofluorescence staining
for FoxO1 is shown (E) (scale bar = 50 mm). Quan-
tified analysis FoxO1 intensity in the nucleus of
pancreatic b cells of Flox, bPik3r1KO, Pik3r2KO,
and bDKO mice is also shown (F). FoxO1 intensity
in nuclei was normalized by FoxO1 intensity in
total islet. Data are presented as the
means ± SEM.
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Role of PI3K in b Cell Functionstransgenic mice (RIP-Cre mice) and mice homozygous for pik3r1
floxed alleles (Floxmice), as described in the Experimental Proce-
dures. However, pik3r1 deletion alone has been reported to acti-
vate downstream of PI3K signaling in the liver (Taniguchi et al.,
2006b). Thus, to almost completely shut down PI3K signaling,
we also generated mice lacking both pik3r1 and pik3r2 genes in
b cells with loss of the pik3r2 gene alone in other tissues (bDKO
mice) using the systemic pik3r2 knockout mice (Pik3r2KO mice)
and bPik3r1KO mice as described in the Experimental Proce-
dures. We assessed the role of PI3K in b cells by comparing
between bPik3r1KO mice and the controls (RIP-Cre mice or Flox
mice) or between bDKO mice and the controls (Pik3r2KO mice
or Flox mice).Cell Metabolism 12, 619–632,To confirm the deletion of class IAPI3K,
we performed immunostaining with
a specific antibody for p85a or the anti-
body for all regulatory subunits (pan-
p85) and found that all regulatory subunits
were diminished in most of the islet cells
of both bPik3r1KO and bDKO mice, and
to a greater degree in bDKOmice (Figures
2A and 2B). Western blot analysis also
revealed that the intensity of bands corre-
sponding to p85a and p85b were signifi-
cantly decreased in islets of both
bPik3r1KO and bDKO mice, although an
increased ratio of non-b to b cells in the
islets of bDKO mice appeared to mask
further reduction in the band intensityowing to the lack of p85b (Figure 2C). Due to a leak in Cre expres-
sion (Kubota et al., 2004), p85a expression was decreased in the
hypothalami of bPik3r1KO and bDKOmice (Figure 2C), although
this did not affect the body weight, food intake, or insulin sensi-
tivity in either group (Figures 3A, 3D, and S1).
To assess how the deletion of pik3r1 affected the downstream
events of PI3K, we examined the production of PIP3 and the local-
ization of Forkhead box O1 (FoxO1) in b cells by immunostaining.
Glucose stimulation resulted in marked impairment of PIP3
production in the islets of bPik3r1KO mouse compared to the
controls (Figure 2D). As a consequence, FoxO1 was localized in
the nucleus of b cells of bPik3r1KO and bDKO mice, as shown
by quantitative analysis of FoxO1 staining (Figures 2E and 2F).December 1, 2010 ª2010 Elsevier Inc. 621
Figure 3. Metabolic Features of bPik3r1KO and bDKO Mice
(A) Profiles of body weight in male bPik3r1KO and bDKO mice with their controls at the indicated ages (n = 9–11).
(B and C) Blood glucose levels after an i.p. injection of glucose (1.5 g/kg BW) in 8-week-oldmale RIP-Cre, Flox, bPik3r1KO (B) (n = 9–11), Pik3r2KO, and bDKO (C)
(n = 10) mice with their controls.
(D) Insulin tolerance test (0.75 U/kg BW) in 8-week-old male Flox, bPik3r1KO, Pik3r2KO, and bDKO mice with their controls (n = 9–11).
(E) Serum insulin concentrations after i.p. injection of glucose (3 g/kg BW) in 12-week-old male Flox, bPik3r1KO, Pik3r2KO, and bDKO mice (n = 5–8).
(F) Static incubation study of islets from 8-week-old Flox, bPik3r1KO, Pik3r2KO, and bDKO mice. Results are shown as an insulin secretion ratio to total insulin
content (n = 5–10). Data are presented as the means ± SEM.
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Role of PI3K in b Cell FunctionsThese data suggest that in b cells, the loss of p85a diminished
PI3K-dependent signaling and that the disruption of all the major
regulatory subunits further shut down the signal in b cells.
bPik3r1KO and bDKO Mice Exhibited Glucose
Intolerance
Both bPik3r1KO and bDKO mice grew normally (Figure 3A), and
all groups displayed normoglycemia in the ad libitum feeding622 Cell Metabolism 12, 619–632, December 1, 2010 ª2010 Elsevierstate (Figure S2A), with similar levels of plasma insulin concen-
tration (Figure S2B).
To investigate metabolic features, we performed glucose
tolerance tests (GTTs) using 8-week-old male mice. There are
some reports that RIP-Cre mice have glucose intolerance due
to toxicity of the Cre expression (Lee et al., 2006). Therefore,
RIP-Cre mice as well as Flox mice were used as controls for
bPik3r1KO mice. bPik3r1KO mice exhibited glucose intoleranceInc.
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Role of PI3K in b Cell Functionscompared to the controls with no difference in glucose levels
during GTT between RIP-Cre and Flox mice (Figure 3B). Thus,
Flox mice were hereafter used as controls for bPik3r1KO mice.
We also found that bDKO mice appeared to show more promi-
nent glucose intolerance than that seen in bPik3r1KO mice,
even though pik3r2 systemic knockout mice exhibited an
insulin-sensitive phenotype (Figure 3C) (Ueki et al., 2002b).
Similar glucose intolerance in bPik3r1KO and bDKO mice was
continuously observed at 12 and 16 weeks of age (data not
shown). Insulin levels of bPik3r1KO and bDKO mice were signif-
icantly decreased during GTT compared to those of controls
(Figure S2C). Insulin tolerance tests (ITTs) were also performed
on 8-week-old male bPik3r1KO and bDKO mice, with no differ-
ence in insulin sensitivity found compared to the controls (Fig-
ure 3D). These data suggested that deletion of the pik3r1 gene
in b cells caused glucose intolerance due to a defect in insulin
secretion.
A GSIS test in vivo using 12-week-old male bPik3r1KO and
bDKO mice revealed decreased GSIS in these mice compared
to the controls (Figure 3E). In particular, early-phase insulin
secretion was significantly impaired in bDKO mice (Figure 3E).
Consistent with the in vivo findings, both 8-week-old bPik3r1KO
and bDKO islets exhibited significantly decreased insulin secre-
tion upon higher concentration of glucose or 50 mM KCl stimu-
lation (Figure 3F). Pancreas perfusion tests were also performed
on 12-week-old male bPik3r1KO and bDKO mice; results indi-
cated attenuated GSIS in both groups (Figure S2D). These
data suggest that both bPik3r1KO and bDKO mice exhibit
impaired GSIS, with a greater degree in bDKOmice, and at least
one of the defects is located at a step downstream of Ca2+ influx.
Deletion of Class IA PI3K Decreased b Cell Mass
Because disruption of IR/IGFR signaling in b cells induced
progressive and robust b cell loss with increased apoptosis
and decreased proliferation (Ueki et al., 2006), we examined
the effect of class IA PI3K deletion, one of the signal transducers
downstream of IR/IGFR, on islet mass. Immunofluorescence
analysis revealed that the morphology of islets was generally
maintained in bPik3r1KO and bDKO mice compared to the
controls, with a slight increase in non-b cells in bDKO islets (Fig-
ure 4A), and that the ratio of islet area to total pancreas did not
differ among all genotypes at 8 weeks of age (Figure 4B).
However, this ratio was decreased in bPik3r1KO and bDKO
mice at 32 weeks of age (Figures 4C and S3). Previous studies
showed that in pancreatic b cells, insulin signaling is indispens-
able for antiapoptosis (Ueki et al., 2006). We found significantly
increased TUNEL-positive b cells of bPik3r1KO and bDKO
mice at 8 weeks of age (Figure 4D), when a reduction in the islet
area was not evident in either group. Surprisingly, however, the
number of bromodeoxyuridine (BrdU)-positive b cells was signif-
icantly increased in bPik3r1KO and bDKO mice at the same age
(Figure 4E). Insulin/IGF-1 signaling mediates the signals via two
major downstream pathways, the PI3K/Akt and Ras/Erk path-
ways (Taniguchi et al., 2006a). The PI3K/Akt pathway mediates
a variety of insulin’s actions, such as glucose metabolism and
antiapoptosis, while the Ras/Erk pathway mainly regulates cell
proliferation, partly in cooperation with the PI3K/Akt pathway
(Burns et al., 2000). In the islets of bPik3r1KO and bDKO mice
where PI3K/Akt signaling was blunted, Erk1/2 phosphorylationCell Mwas markedly enhanced compared to that seen in the controls
(Figures 4F and 4G). This upregulation of the Erk pathway, which
activates cell proliferation, may compensate for the increased
apoptosis by suppressing PI3K and hence may maintain the
b cell mass of younger bPik3r1KO and bDKO mice.
bDKO Mice Showed Dysfunctions in Insulin Secretion
To explore themechanism underlying the impaired GSIS by PI3K
deletion, we directly analyzed the islets by two-photon excitation
imaging, which allowed us to observe exocytotic events in the
insulin granule and Ca2+ influx in intact islets in 8-week-old
male bDKO mice, which appeared to have more profound
defects than did the bPik3r1KO mice (Takahashi et al., 2002).
The number of exocytotic events associated with high glucose
stimulation was significantly decreased in bDKO islets within
10 min (Figure 5A). Levels of Ca2+ influx in individual b cells
were also assessed using the Ca2+ indicator, fura-2. In b cells
of bDKOmice, the levels of Ca2+ influx upon glucose stimulation
were significantly decreased compared to those of Flox or
Pik3r2KO mice (Figure 5B), suggesting a defect between the
glucose transport and Ca2+ influx steps.
To explore the defect responsible for impaired glucose-
induced Ca2+ influx, we conducted perforated whole-cell clamp
experiments. The results showed that conductance densities of
ATP-sensitive K+ (KATP) channels, resting membrane potentials,
and latencies of KATP channel responsiveness to glucose were
not different between Pik3r2KO and bDKO at the single b cell
level (Figures S4A–S4D). At the whole-islet level, ATP production
in response to glucose was slightly, but not significantly,
decreased in bDKO mice, with only modest reductions in some
of the mitochondria-related gene expressions (Figures S4E
and S4F).
On the other hand, we found that both in Flox and in Pik3r2KO
islets, Ca2+ influx of almost all the b cells occurred simulta-
neously (Figures 5C and 5D and Movies S1 and S2). In contrast,
in bDKO islets, b cells lost synchronicity in secreting insulin in
response to an intracellular Ca2+ rise, and individual b cells
secreted insulin after various latencies (Figures 5C and 5D and
Movie S3). As a consequence, total Ca2+ influx in the whole islet
exhibited a blunted curve in bDKO islets (Figure 5D, upper panel),
similar to that of bIRKO islets (Otani et al., 2004).
Insulin exocytosiswas investigatedwhen triggeredwith a large
and rapid increase in Ca2+ influx induced by photolysis of
a caged-Ca2+ compound, which was artificial but allowed us to
determine a defect downstream of Ca2+ influx (Takahashi
et al., 2004). Even though the same levels of Ca2+ influx were
provoked (Figure 5E), the exocytosis events were markedly
reduced in bDKO islets (Figure 5F), suggesting that bDKO mice
also have a defect downstream of the Ca2+ influx in their exocy-
tosis machinery. Taken together, these results suggest that
defects in exocytosis machinery and cell-cell synchronization
may be causally involved, at least partly, in the impaired GSIS
in bDKO islets.
b Cell Functions Were Regulated by PI3K Signaling
To explore the molecular mechanism causing the impaired GSIS
associated with deletion of class IA PI3K, we extensively exam-
ined the expression levels of genes regulating b cell functions by
quantitative real-time PCR in 8-week-old male bDKO mice andetabolism 12, 619–632, December 1, 2010 ª2010 Elsevier Inc. 623
Figure 4. Alterations in b Cell Mass, Apoptosis, and Cell Proliferation in Pancreas with Upregulated Phosphorylation of Erk1/2 in bPik3r1KO
and bDKO Islets
(A) Staining with antibodies to insulin (green) and glucagon (red) and nuclear stain DAPI using pancreatic sections from 8-week-old male mice of indicated geno-
types (magnification: 203).
(B) Histological analysis of pancreatic b cell area in Flox, bPik3r1KO, Pik3r2KO, and bDKO mice at 8 weeks of age.
(C) Histological analysis of pancreatic b cell area in Flox, bPik3r1KO, Pik3r2KO, and bDKO mice at 32 weeks of age.
(D) TUNEL staining of pancreatic sections at 8 weeks of age.
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Role of PI3K in b Cell Functionstheir controls. Deletion of class IA PI3K did not affect the expres-
sion of gck (Gck), kcnj11 (Kir6.2), or abcc8 (Sur1) (Figure 6A). In
contrast, the expression of slc2l2 (Glut2) was significantly
reduced in bDKOmice (Figure 6A), although it is unclear whether
this contributes to the decreased level of Ca2+ influx in bDKO
mice. The expression level of pdx1 was reduced in bDKO mice
compared to that seen in the controls (Figure 6B), consistent
with the increase in nuclear FoxO1. Exocytosis from the insulin
granules of b cells is largely dependent on soluble N-ethylmalei-
mide attachment protein receptor (SNARE) complex proteins,
including SNAP25, VAMP2, Syntaxin 1a, and Rab27a (Kasai
et al., 2005; Nagamatsu et al., 1999; Takahashi et al., 2004).
We found that the cluster of SNARE complex genes was
decreased significantly, as estimated by mRNA and protein
levels in bDKO mice (Figures 6C and 6D). The reduced expres-
sion of these genes may account for an aggravated alteration
in exocytosis and vesicular movement in class IA PI3K-deficient
b cells. On the other hand, pancreatic b cells communicate with
each other thorough gap-junction channels, which are
composed of Connexin36 protein hexamer (Nlend et al., 2006).
Indeed, deletion of gjd2 encoding Connexin36 results in loss of
synchronization in Ca2+ oscillations and impaired GSIS (Ravier
et al., 2005). Consistent with these findings, the mRNA and
protein expressions of gjd2 in bDKO islets were significantly
decreased compared to the controls (Figures 6C and 6D). Similar
changes in expressions of these genes were also observed in
bPik3r1KO islets (data not shown).
To assess whether the loss of PI3K signaling in b cells directly
affected the reduced expression in SNARE complex genes and
gjd2, we conducted in silico analyses of the promoter regions
of these genes and found that they all have potential FoxO1
binding sites. Given that FoxO1 is preferentially localized in the
nucleus in the b cells of bDKO mice due to the blunted Akt
activity, it is possible that FoxO1 directly binds to the promoters
of these genes, suppressing their expression. The forced activa-
tion of Akt would exclude FoxO1 from the nucleus and restore
the expression of these genes. To assess this possibility, we ex-
pressed a constitutively active form of FoxO1 (FoxO1-3A)
adenovirus in 8- to 10-week-old islets. Indeed, expression of
FoxO1-3A resulted in a significant reduction in expression of
gjd2 and snap25, of which putative FoxO1 binding sites are
conserved across species, human, mouse, and rat (Figure 6E).
In contrast, the expression of a constitutively active form of Akt
(GagAkt) in the isolated islets of 8- to 10-week-old male bDKO
mice significantly increased the expression of all SNARE
complex genes and gjd2 compared to lacZ infection (Figure 6F).
Moreover, the expression of GagAkt in the isolated islets of 8- to
10-week-old male bDKO mice significantly augmented GSIS in
bDKO islets (Figure 6G).
Impaired Exocytosis and Synchronization in db/db
To evaluate the contribution of these mechanisms to obesity-
induced diabetes, we also observed the db/db islets by using
two-photon microscopy. In the isolated islets of 10-week-old
male db/db mice, exocytosis was found to decrease after(E) BrdU incorporation into b cell nuclei of 8-week-old male Flox, bPik3r1KO, Pik
(F) Western blotting by phospho-Erk1/2 and total Erk in islets isolated from each
(G) Quantified by densitometry of the western blotting. Data are presented as th
Cell Mglucose stimulation (Figure 7A) and caged-Ca2+ stimulation (Fig-
ure 7B). Moreover, a defect in cell-cell synchronization in terms
of Ca2+ influx similar to that seen in bDKO islets was observed
(Figures 7C and 7D and Movie S4). Furthermore, the expression
levels of gjd2 and SNARE complex genes in db/db islets
progressively declined to much lower levels compared to the
age-matched controls (Figure 7D). This suggested that PI3K/
Akt signaling may have been downregulated in the islets of these
mice. Indeed, immunohistochemistry using phospho-Akt anti-
body revealed that Akt activity was almost abolished in the islets
of db/db mice at 10 weeks of age (Figure 7E).
DISCUSSION
In T2DM patients, insulin signaling, especially PI3K/Akt
signaling, is known to be diminished in muscle and liver owing
to insulin resistance and/or decreased circulating insulin, leading
to a reduction in glucose metabolism and subsequent hypergly-
cemia (Bandyopadhyay et al., 2005). We and others have previ-
ously shown that b cells also possess insulin signaling systems
that play a critical role in the regulation of b cell mass and func-
tion (Kulkarni et al., 1999, 2002; Leibiger et al., 2001, 2008; Ueki
et al., 2006). It is possible that decreased insulin signaling in
b cells, resulting from either insulin resistance or decreased
insulin secretion in these cells, may cause loss of b cell function
and mass, leading to hypoinsulinemia and subsequent
hyperglycemia.
We asked whether insulin signaling in the b cell in db/dbmice,
an obese diabetic animal model, would play a role in the
compensatory hyperinsulinemia in response to insulin resistance
and the exacerbated hyperglycemia seen after decompensation.
Indeed, as db/db mice grow older and obese, hyperglycemia
and defects in insulin secretion become evident, and phosphor-
ylated Akt levels significantly decrease in b cells, indicating
impaired insulin signaling within these cells. In accordance with
the age-dependent impairment of insulin secretion and
decreased b cell mass, expressions of insulin signaling
molecules, such as class IA PI3K, decline. In addition to the
reductions in expression of these molecules, posttranslational
modulation of signaling molecules by increased oxidative stress,
ER stress, and inflammation may further attenuate insulin
signaling (Evans et al., 2003; Hotamisligil, 2006). These results
suggest the possibility that insulin signaling in b cells plays
a crucial role in the maintenance of b cell mass and functions
in response to insulin resistance through the class IA PI3K
pathway. Thus, we have tried to explore the roles of class IA
PI3K in maintaining b cell functions and mass using the mice
lacking all the major regulatory subunits of class IA PI3K specif-
ically in b cells.
In b cells, unlike in hepatocytes, deletion of pik3r1 markedly
suppresses downstream signaling, such as Akt activation, and
results in impaired glucose tolerance with a defect in GSIS.
Double knockout of pik3r1 and pik3r2 in b cells (bDKO), which
further shuts down the downstream signaling, causes an even
greater defect in GSIS and decreased b cell mass. These defects3r2KO, and bDKO mice.
genotype at 8 weeks of age.
e means ± SEM.
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Figure 5. Glucose-Stimulated Exocytotic Events Estimated by Two-Photon Microscopy Imaging
(A) Left: Glucose-stimulated exocytotic events averaged for 5–6 islets in each genotype, normalized by an arbitrary area (800 mm2) of islets. Right: Glucose-stim-
ulated exocytotic events in 10 min.
(B) Glucose-stimulated Ca2+ influx in single b cell measured by Ca2+ indicator fura-2. Fura-2 fluorescence (F) was normalized by the resting fluorescence (F0). F0
and F stand for resting and poststimulation fluorescence, respectively.
(C and D) Defect of cell-cell synchronization in bDKO islets (n = 5–6) estimated by two-photon microscopy imaging. Data were acquired from islets from 8-week-
old male Flox, Pik3r2KO, and bDKOmice. SEM of the Ca2+ influx latencies of all cells in an islet were measured in Flox, Pik3r2KO, and bDKOmice (C). Each trace
showed the alterations of the Ca2+ concentrations in a whole islet of indicated genotype (D, upper). The alterations of the cytosolic Ca2+ concentrations of single
b cell from one islet of Flox, Pik3r2KO, and bDKOmice are shown in the lower panel of (D). Each trace showed the alteration of the cytosolic Ca2+ concentrations
recorded from single b cell in one islet.
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Role of PI3K in b Cell Functionsare caused by severely impaired insulin secretion and a robust
increase in apoptosis. Interestingly, bDKO mice do not develop
overt diabetes, unlike insulin/IGF-1 receptor double knockout
mice in which both PI3K and the Erk pathways are suppressed,
even considering the fact that pik3r2 null mice exhibit a modest
insulin-sensitive phenotype (Ueki et al., 2002b, 2006).
The PI3K/Akt pathway can negatively affect IR/IGFR signaling
viamultiplemechanisms, such as serine phosphorylation of IRS1
and Raf (Um et al., 2004). Abrogation of this signal may enhance
tyrosine phosphorylation of IRS proteins and reduce serine
phosphorylation of Raf, ultimately increasing the signaling to
the Raf/Erk pathway. Indeed, bDKO islets exhibit significantly
increased phosphorylation of Erk1/2 as well as increased BrdU
incorporation. Thus, bDKO mice can preserve b cell mass
presumably at a level necessary to maintain normoglycemia,
despite a marked increase in apoptosis and impaired insulin
secretion.
Thecurrent studyhas revealed that class IAPI3Kplaysa crucial
role in maintaining b cell function through regulating cell-cell
synchronization associated with Ca2+ influx and exocytosis
machinery. Previous studies have reported that gap-junction
channels composed of Connexin36 hexamer regulate the cell-
cell synchronization in b cells throughdirect exchanges ofmetab-
olites and ions and that these communications are important for
proper GSIS and oscillations (Nlend et al., 2006; Ravier et al.,
2005). In bDKO islets, the expression of gjd2 is significantly
reduced. Moreover, db/db islets also show impaired cell-cell
synchronization similar to that seen in the bDKO islets, with
decreased expression of gjd2 in accordance with decreased
insulin secretion. Thus, the impairedCa2+ influxcanbeaccounted
for, at least in part, by the impaired cell-cell synchronization.
On the other hand, ATP production and the expressions of
slc2l2 and mitochondria-related genes are slightly decreased
in bDKO islets, consistent with the recent report that the expres-
sion of slc2l2 and mitochondrial functions are regulated by
insulin signaling in b cells (Assmann et al., 2009; Liu et al.,
2009). Although electrophysiological experiments fail to indicate
significant impairment of the steps upstream of Ca2+ influx, at
least at the single b cell level, these defects might also contribute
to the impairment of GSIS by deletion of class IA PI3K. Mean-
while, the mRNA expression of gck shows no reduction in
bDKO islets, although gck expression is reduced both in bIRKO
and in bIGFRKO islets. Recently, it has been reported that class II
PI3K (PI3K-C2a) may play an important role in GSIS in pancreatic
b cells downstream of the IR (Leibiger et al., 2010). In this report,
impairment of class II PI3K signaling has been shown to result in
the reduction of gck expression. Thus, the expression of gck
might be regulated through class II PI3K signaling, not through
class IA PI3K signaling downstream of IR.
Insulin secretion occurs to a much lesser extent in bDKO islets
compared to Pik3r2KO islets, even when using caged-Ca2+
stimulation, suggesting another defect downstream of Ca2+
influx, such as in the exocytosis machinery (Takahashi et al.,
2004). Indeed, expressions of SNARE complex genes are mark-(E and F) Exocytotic events triggered by photolysis of a caged-Ca2+ compound. A
is shown in (E). Each trace showed the cytosolic Ca2+ concentration recorded from
an arbitrary area (800 mm2) of islets, are shown in (F). Data are presented as the
Cell Medly reduced in the islets of bDKO mice, and these reductions
can contribute to defects in insulin secretion downstream of
Ca2+ channels.
Are these insulin secretion defects directly caused by ablating
PI3K signaling? Expression of FoxO1-3A in the Pik3r2KO islets
reduces the expression of snap25 and gjd2, both of which
have the putative FoxO1 binding sites conserved across species
in their promoter region, suggesting that FoxO1 binds to the
promoter regions and inhibits the transcription of these genes.
Thus, activation of PI3K/Akt appears to promote nuclear excur-
sion of FoxO1, thereby increasing the expression levels of these
genes. Indeed, expression of GagAkt normalizes the expression
of these genes with other SNARE complex genes, such as
vamp2, stx1a, and rab27a. These data also suggest that other
transcription factor(s) may regulate the expression of other
SNARE complex genes through Akt activation, independently
of FoxO1. Importantly, restoration of the expression of these
genes by Akt activation almost completely normalizes GSIS
in vitro.
T2DM patients show decreased islet mRNA and protein
expressions of SNAP25, Syntaxin 1a, and VAMP2 compared to
nondiabetic subjects (Ostenson et al., 2006). Moreover, Con-
nexin36 is also expressed in human islets, and it has been sug-
gested that this may play a role in insulin secretion (Serre-Beinier
et al., 2009). Taken together, these findings suggest that these
SNARE complex proteins and Connexin36, whose expression
is regulated by the PI3K/Akt pathway downstream of insulin
signaling, may control the function of the human b cell. In addi-
tion, downregulation of these proteins by impaired PI3K/Akt
activity may play a crucial role in the deteriorated GSIS, one of
the characteristics of T2DM.
Similar to db/dbmice in the current study, human obese T2DM
patients show hyperinsulinemia with a defect in early-phase
GSIS at the early stage of T2DM and then develop severe dia-
betes with hypoinsulinemia and reduced b cell mass in the
advanced stage (Butler et al., 2003; Rhodes, 2005). It is possible
that insulin resistance in b cells inhibits PI3K activity by some
mechanisms, such as decreased expressions of insulin signaling
molecules, including class IA PI3K. As shown in bDKO mice,
decreased PI3K activity in b cells can impair insulin secretion
by suppressing glucose metabolism, cell-cell communication,
and SNARE proteins and by increasing apoptosis. However,
b cell mass can be maintained by enhanced Erk signaling
induced by decreased PI3K activity as long as input of the insulin
signal to activate IRS/Erk pathway is preserved by hyperinsuline-
mia in response to peripheral insulin resistance.Meanwhile, at an
advanced stage of diabetes, severely impaired IR activation due
to further reductions in expression levels of IR/IRS2/PI3K and
relative hypoinsulinemia may abolish both PI3K/Akt and Erk
activity. This leads to exacerbation of impaired insulin secretion,
decreased b cell mass, and subsequent hypoinsulinemia,
making a vicious cycle.
Taken together, class IA PI3K in b cells is indispensable for
normal insulin secretion mainly through controlling intracellularlteration of cytosolic Ca2+ concentrations provoked by caged-Ca2+ stimulation
a single islet. Exocytotic events upon caged-Ca2+ stimulation, normalized by
means ± SEM.
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Figure 6. Analysis of Gene Expressions in the Islets of 8-Week-OldMale Pik3r2KO and bDKOMice and Effects of Constitutively Active FoxO1
(FoxO1-3A) or Akt (GagAkt) on the Gene Expression and Insulin Secretion
(A) The expression levels of gck, kcnj11, abcc8, and slc2l2 in Pik3r2KO and bDKO islets (n = 5–6).
(B) The expression levels of mature onset diabetes of the young (MODY) genes in Pik3r2KO and bDKO islets.
(C) The expression levels of SNARE complex genes, snap25, vamp2, stx1a, rab27a, and gjd2.
(D) Protein expression of SNARE complex and Connexin36 in Pik3r2KO and bDKO islets assessed by western blotting (n = 4).
(E) Effects of constitutively active FoxO1 (FoxO1-3A) in the islet isolated from 8-week-old male Pik3r2KO mice on the mRNA levels of the indicated genes.
(F) Effects of constitutively active Akt (GagAkt) in the islet isolated from 8-week-old male bDKO mice on the mRNA levels of the indicated genes.
(G) Effects of constitutively active Akt (GagAkt) in the islets isolated from 8-week-old male bDKO mice on glucose-stimulated insulin secretion estimated by the
static incubation. Data are presented as the means ± SEM.
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Figure 7. Analyses of Exocytotic Events of the Islets of db/db Mice by the Two-Photon Microscopy Imaging and Gene Expressions
(A) Left: analysis of glucose-stimulated exocytotic events averaged for five islets, normalized by an arbitrary area (800 mm2) of islets. Right: measurements of
exocytotic events in 10 min.
(B) Exocytotic events upon caged-Ca2+ stimulation, normalized by an arbitrary area (800 mm2) of islets.
(C) SEM of the Ca2+ influx latencies upon glucose stimulation (n = 5).
(D) Upper: Each trace showed the alterations of the Ca2+ concentrations in a whole islet. Lower: Representative recordings from two-photon microscopy imaging
showdefects of cell-cell synchronization in db/db islets (n = 5–7). Each trace showed the changes of the cytosolic Ca2+ concentration of a single cell from one islet
of +/+ mice and db/db mice.
(E) mRNA expressions of gjd2 and SNARE complex genes estimated by quantitative real-time PCR in the islets of db/db and +/+ mice at 6, 10, and 14 weeks of
age (n = 5–6).
(F) Immunohistochemical analysis of pancreas sections from 10-week-old db/db and +/+ mice; staining for phosphorylation of Akt in the db/db islets. Data are
presented as the means ± SEM.
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Cell Metabolism
Role of PI3K in b Cell FunctionsCa2+ levels, maintaining cell-cell synchronization, and regulating
SNARE complex proteins. It is also important for antiapoptosis
and regulates b cell mass, in cooperation with cell proliferation
controlled by the Erk pathway. Thus, enhancing the class IA
PI3K pathway, not only in peripheral tissues but also in b cells,
may provide a therapeutic strategy for T2DM.
EXPERIMENTAL PROCEDURES
Animals
The pik3r1 floxed mice, pik3r2 knockout mice, and RIP-Cre transgenic mice
have all been described previously (Luo et al., 2005). Mice were maintained
on a 129Sv-C57BL/6-FVB mixed background. Animals were housed on
a 12 hr light-dark cycle. Animal care and experimentations were approved
by the Animal Care and Use Committee of the University of Tokyo. All exper-
iments in this study were performed on male mice. By mating pik3r1 heterozy-
gous floxedmice carrying a RIP-Cre transgenic allele with heterozygous pik3r1
floxed mice, we generated bPik3r1KO mice and the controls (Flox mice and
RIP-Cremice) in same littermates. Alternatively, bymating pik3r1 homozygous
floxed mice carrying RIP-Cre transgenic allele with pik3r1 homozygous floxed
mice, we generated bPik3r1KO mice and the control Flox mice. Mating pik3r1
homozygous floxed mice carrying a RIP-Cre transgenic allele (with pik3r2
homozygous knockout alleles) with pik3r1 homozygous floxed mice (with
pik3r2 homozygous knockout alleles) brought bDKO mice and the control
Pik3r2KO mice. We confirmed the Cre-mediated deletion of pik3r1 by PCR
using DNA and by quantitative real-time PCR using RNA extracted from
bPik3r1KO islets and bDKO islets and detected the remaining wild-type
gene products to some extent, presumably due to the contamination of non-
b cells.
Metabolic Studies
GTT and ITT were performed as described previously (Ueki et al., 2002b). For
GTT, micewere fasted for 16 hr, and blood samples were obtained at indicated
time points after intraperitoneal (i.p.) injection of D-glucose (WAKO; Osaka,
Japan). For ITT, mice were injected with the insulin solution (HumalinR, Eli Lilly;
Indianapolis, IN) intraperitoneally. Blood glucose levels were checked at indi-
cated time points (Glutest Pro, Sanwa Kagaku Kenkyusho;Mie, Japan). Serum
insulin levels were measured using a radioimmunoassay insulin kit (Institute of
Isotopes, Budapest) in accordance with the manufacturer’s instructions. For
first-phase GSIS testing, mice were fasted for 16 hr, and blood samples
were obtained at indicated time points after i.p. injection of D-glucose
(3.0 g/kg BW).
Islet Isolation and Measurement of Insulin Content
Islets were isolated by Liberase RI (Roche) pancreatic perfusion and subse-
quent digestion for 24 min at 37C (Kulkarni et al., 1999). Islets were picked
manually and then immediately used for secretion studies or were maintained
in Hank’s balanced salt solution (HBSS) (Sigma) buffer supplemented with
10% FCS and 25 mM HEPES buffer.
Batch Incubation Experiments andMeasurement of ATP Production
Freshly isolated islets were maintained in Krebs-Ringer Bicarbonate (KRB)
buffer (129 mM NaCl, 4.8 mM KCl, 1.2 mM MgSO4, 1.2 mM KH2PO4,
2.5 mM CaCl2, 5 mM NaHCO3, and 10 mM HEPES [adjusted to pH 7.4]) con-
taining 0.2% bovine serum albumin supplemented with 2.8 mM glucose for
30min at 37C. The islets were incubated for 30min in the same buffer contain-
ing indicated stimulants. For measurement of insulin content, islets were
extracted by the acid ethanol overnight incubation at 20C.
Quantitative RT-PCR Analysis
Quantitative RT-PCR was performed by PRISM 7900HT (ABI; Carlsbad, CA).
For RT-PCR quantification of islets, all mice were killed in ad libitum state,
and islets were processed as described earlier. Total RNA was extracted
from islets using an RNeasy kit (QIAGEN). cDNA was prepared from total
RNA using a High Capacity cDNA Reverse Transcription Kit (ABI). Gene
expression levels were normalized to the expression of cyclophilin in each
sample. All primers and probes of genes were purchased from ABI.630 Cell Metabolism 12, 619–632, December 1, 2010 ª2010 ElsevierImmunostaining and Morphometric Analysis of Islets
Immunohistochemical and morphometric analyses of pancreas sections were
performed using methods described earlier (Ueki et al., 2006) with a slight
modification. Four or five mice of each genotype at 8 and 32 weeks of age
were subjected to morphometric analysis. Sections were stained with
antibodies to insulin (DAKO; Glostrup, Denmark), glucagon (DAKO), phos-
pho-Akt (Ser473) (Cell Signaling; Danvers, MA), FoxO1 (Cell Signaling and
homemade cocktail), p85 (N-SH domain) (Upstate; Charlottesville, VA), p85a
(MBL; Woburn, MA), PIP3 (MBL), phospho-Erk (Cell Signaling), and b-catenin
(BD Biosciences Pharmingen; San Diego, CA). For morphometric analysis,
images of islets were traced manually and analyzed with the use of ImageJ
software (NIH). Glucose stimulation for PIP3 staining was conducted after
mice were fasted for 16 hr and then sacrificed 10 min after i.p. injection of
D-glucose (3 g/kg BW in saline) (WAKO). Cell proliferation was detected by
DNA replication using BrdU. BrdU incorporation was analyzed as previously
described (Kubota et al., 2004). The TUNEL staining was performed using
the Roche Cell Death Detection Kit.
Two-Photon Excitation Imaging
Two-photon excitation imaging of islets was performed as previously
described (Hatakeyama et al., 2007; Takahashi et al., 2004). Exocytotic events
were counted in a region of interest with an area of 3200–5200 mm2 and were
normalized to an area of 800 mm2. Ca2+ measurements were performed using
fura-2 as the Ca2+ indicator. Fura-2 fluorescence (F) was normalized by the
resting fluorescence (F0). The increase of Ca
2+ concentration is calculated
by (F0  F) / F0, where F0 and F stand for resting and poststimulation fluores-
cence, respectively. Islets loaded with 30 mM NP-EGTA-AM (Invitrogen) for
30 min were used for experiments.
Statistical Analyses
Data are presented asmean ± SEMand analyzed by Student’s t test or ANOVA
followed by post hoc comparisons. The null hypothesis is rejected at p < 0.05.
Statistical significance is displayed as *p < 0.05 or **p < 0.01.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Supplemental References, four figures, and four movies and can be found
with this article online at doi:10.1016/j.cmet.2010.11.005.
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